This episode is brought to you by The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
Today, we speak with Raviv Pryluk, CEO of PhaseV, a company leveraging reinforcement learning and causal machine learning to design and run adaptive clinical trials that improve success rates while reducing cost and time.
Raviv is an experienced executive with a track record across engineering, data science, biotechnology, and computational neuroscience. His passion lies in solving complex multidisciplinary problems that have a broad, positive impact on the world.
Since its founding, PhaseV has expanded from trial design into execution, analysis, and portfolio planning, now supporting over 30 biopharma and CRO customers worldwide with measurable results, including cutting development costs by up to 50%.
I am your host RJ Lumba. We hope you enjoy the show. If you like the episode click to follow.
